Can people safely use a fractional laser at home? A 124-person trial
Short answer
In this multicentre trial, 124 people treated their own eye-area wrinkles with a handheld non-ablative fractional laser, following written instructions. Blinded physicians reviewing photos rated wrinkles one grade better in 90% of people after daily treatment and 79% after maintenance. The main side effect was short-lived redness. There was no control group.
- Study
- Leyden J, Stephens TJ, Herndon JH. J Am Acad Dermatol. 2012;67(5):975-84.
- Design
- Multicentre trial, no control group
- People
- 124 completed
- Topic
- Periorbital wrinkles
Why it matters
It was one of the first published trials showing that ordinary users could self-treat with a home fractional laser, the device category that includes Tria FRX and MimiSilk Iris.
What they did
- Ran two studies in which participants used a handheld non-ablative fractional laser on their own eye area.
- Used an active phase of daily treatments, then a maintenance phase of twice-weekly treatments.
- Followed 36 people for up to 5 months after maintenance; images were graded by blinded physicians on the Fitzpatrick Wrinkle Scale.
What they found
- All 124 people who finished could use the device from written instructions.
- Wrinkle scores improved by at least one grade in 90% after the active phase and 79% after maintenance.
- The most common side effect was temporary redness after treatment.
What it cannot tell you
- No control group, which the authors list as a limitation.
- Single-blinded groups.
- The abstract does not name the device brand or wavelength.
Takeaway
Self-treatment with a home fractional laser looked practical and tolerable, and blinded graders saw improvement. Without a control group, the size of the true effect is uncertain.
Matching devices
Devices whose published technology match this study: MimiSilk Iris and Tria FRX. None of them was the device tested unless the study names it.
Not medical advice. Summary based on the published abstract; read the full paper for detail.